OHSU in the news

OHSU starts new trial using antibodies for COVID-19 treatment

KATU-TV October 08, 2020
While announcing OHSU’s involvement in an international clinical trial assessing monoclonal antibodies for COVID therapy, Akram Khan, M.D., notes antibodies can decrease viral replication, “allowing the body to repair and heal itself.”

OHA to review COVID-19 vaccine data before approving use in Oregon

KPTV October 07, 2020
In a story about Oregon wanting to review COVID vaccine clinical trial data before allowing federally approved vaccines to be administered in the state, Mark Slifka, Ph.D., notes the COVID-19 vaccine development process has been accelerated, but vaccine trials still needs to involve thousands of people to ensure experimental vaccines are safe.

New Zealand's Ubiquitome signs NIH RADx contract

Ubiquitome October 06, 2020
A Ubiquitome press release includes comment from Steven Kazmierczak, Ph.D., who led clinical studies for Liberty16 mobile PCR technology. He says: “The Liberty16 came through as fast, accurate and competitive for the cost of testing and the device itself.”
See more stories